		Technical Data
V2100-03	Varicella Zoster Virus, Glycoprotein B (VZV Glycoprotein B, VZV gB, gp140/62, gpII, Human Herpes Virus 3, Human Herpesvirus 3, HHV3 gB, ORF31)

Description:
Varicella Zoster Virus (VZV) is a member of the human herpes virus family which causes two distinct clinical manifestations: childhood chickenpox (Varicella) and shingles (Zoster). Varicella is the outcome of the primary infection with VZV. Whereas, Zoster is the result of VZV reactivation from latently infected sensory ganglia which occurs predominantly in aging and immunosuppressed individuals.

Applications:
Suitable for use in Immunofluorescence and ELISA. Other applications not tested.

Recommended Dilutions:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Type	Isotype	Clone	Grade
Mab	IgG1	9F460	Affinity Purified

Size		Storage	Shipping	Source	Host
100ug		-20°C	Blue Ice		Mouse

Concentration:

~1mg/ml

Immunogen:

VZV Glycoprotein B.

Purity:

Purified by affinity chromatography.

Form

Supplied as a liquid in PBS, pH 7.4.

Specificity:

Recognizes VZV Glycoprotein B. Recognizes a confirmational epitope on the protein and therefore can’t be used in experiments requiring protein denaturation.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

1. Jacquet, A., et al., Virus Res. 53(2): 197-207 (1998).